The Microdose
Subscribe
Sign in
Home
This Week in Psychedelics
5 Questions
Spotlight
Opinion
Podcast
Archive
About
Latest
Top
Discussions
A New Psychedelic Mushroom Gets the Artistic Treatment
A recently discovered species of psilocybe from Ecuador sparks questions about art and conservation.
18 hrs ago
•
Whitney Bauck
37
Share this post
The Microdose
A New Psychedelic Mushroom Gets the Artistic Treatment
Copy link
Facebook
Email
Notes
More
Beckley announces new results for 5-MeO-DMT drug; Updates on psychedelics and the Trump Administration; Data and lessons from Health…
Plus: More psilocybin dispensary raids in Ontario, and Rats see trippy movement, too
Jul 11
•
jane c. hu
11
Share this post
The Microdose
Beckley announces new results for 5-MeO-DMT drug; Updates on psychedelics and the Trump Administration; Data and lessons from Health Canada’s psilocybin access program
Copy link
Facebook
Email
Notes
More
Don Quixote, DMT, psychedelic tourism: 5 Questions for literature professor Alberto Ribas-Casasayas
Ribas-Casasayas discusses perspectives on psychedelics from Latin American.
Jul 7
•
jane c. hu
51
Share this post
The Microdose
Don Quixote, DMT, psychedelic tourism: 5 Questions for literature professor Alberto Ribas-Casasayas
Copy link
Facebook
Email
Notes
More
June 2025
Compass announces Phase 3 synthetic psilocybin results; DEA moves two psychoactive research chemicals to Schedule I; and New Zealand…
Plus: Iowa governor vetoes Compass trigger law bill, and Will travel for psychedelics
Jun 27
•
jane c. hu
33
Share this post
The Microdose
Compass announces Phase 3 synthetic psilocybin results; DEA moves two psychoactive research chemicals to Schedule I; and New Zealand Ministry of Health approves prescription psilocybin
Copy link
Facebook
Email
Notes
More
The art of relinquishing control: 5 Questions for artist Matthew Palladino
Palladino discusses his work and its connection to psychedelics.
Jun 23
•
jane c. hu
35
Share this post
The Microdose
The art of relinquishing control: 5 Questions for artist Matthew Palladino
Copy link
Facebook
Email
Notes
More
Live from Psychedelic Science 2025
Day 3 from The Integration.
Jun 21
•
jane c. hu
39
Share this post
The Microdose
Live from Psychedelic Science 2025
Copy link
Facebook
Email
Notes
More
Psychedelic Science 2025
Day 2 of The Integration
Jun 19
•
jane c. hu
33
Share this post
The Microdose
Psychedelic Science 2025
Copy link
Facebook
Email
Notes
More
Live from Psychedelic Science 2025: A dispatch from Denver
Day 1 of The Integration.
Jun 19
•
jane c. hu
53
Share this post
The Microdose
Live from Psychedelic Science 2025: A dispatch from Denver
Copy link
Facebook
Email
Notes
More
Shamanism and psychedelics: 5 Questions for Manvir Singh
Singh discusses convergences between shamanism and psychedelics, and their role in modern spirituality.
Jun 16
•
jane c. hu
39
Share this post
The Microdose
Shamanism and psychedelics: 5 Questions for Manvir Singh
Copy link
Facebook
Email
Notes
More
Texas passes nation’s first ibogaine research funding bill; Colorado’s first Natural Medicine client; and Psilocybin’s effects wane a year…
Plus: Oregon Psilocybin services releases its first quarterly demographic data report and Could the Czech Republic be the first EU country to approve…
Jun 13
•
jane c. hu
24
Share this post
The Microdose
Texas passes nation’s first ibogaine research funding bill; Colorado’s first Natural Medicine client; and Psilocybin’s effects wane a year after dosing
Copy link
Facebook
Email
Notes
More
MDMA for narcissism? 5 Questions for psychoanalyst and psychiatrist Alexa Albert
Albert discusses why MDMA might help people with narcissism, and the details of a pilot study that aims to explore that.
Jun 9
•
jane c. hu
55
Share this post
The Microdose
MDMA for narcissism? 5 Questions for psychoanalyst and psychiatrist Alexa Albert
Copy link
Facebook
Email
Notes
More
Ketamine company sues newspaper; atai to merge with Beckley Psytech; and Oregon disabilities case continues
Plus: Long-anticipated study on religious leaders published, and Maine psilocybin decriminalization bill advances
Jun 6
•
jane c. hu
32
Share this post
The Microdose
Ketamine company sues newspaper; atai to merge with Beckley Psytech; and Oregon disabilities case continues
Copy link
Facebook
Email
Notes
More
Share
Copy link
Facebook
Email
Notes
More
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts